CANC Holdings Information

CANC is an equity ETF with a total of 59 individual holdings. The top holdings are Revolution Medicines stock at 6.02%, Eli Lilly and Company at 5.10%, Cogent Biosciences at 4.94%, Novartis AG at 4.02%, and Roche Holding AG at 3.78%.

Total Holdings

Top 10 Percentage

40.74%

Asset Class

Equity

ETF Category

Health

Assets

178.42M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.02%	63,114
2	LLY	Eli Lilly and Company	5.10%	8,252
3	COGT	Cogent Biosciences, Inc.	4.94%	246,775
4	SWX: NOVN	Novartis AG	4.02%	51,180
5	RHHBY	Roche Holding AG	3.78%	144,703
6	MRK	Merck & Co., Inc.	3.49%	54,118
7	LEGN	Legend Biotech Corporation	3.40%	245,666
8	JNJ	Johnson & Johnson	3.39%	25,377
9	IMNM	Immunome, Inc.	3.34%	273,957
10	ABBV	AbbVie Inc.	3.24%	25,446
11	BMY	Bristol-Myers Squibb Company	3.20%	110,151
12	LON: AZN	AstraZeneca PLC	3.05%	31,742
13	EXEL	Exelixis, Inc.	2.83%	98,975
14	IDYA	IDEAYA Biosciences, Inc.	2.81%	138,777
15	AMGN	Amgen Inc.	2.54%	13,772
16	CGON	CG Oncology, Inc.	2.43%	70,182
17	CELC	Celcuity Inc.	2.42%	41,792
18	GMAB	Genmab A/S	2.37%	162,291
19	BBIO	BridgeBio Pharma, Inc.	2.32%	59,418
20	FXFXX	First American Treasury Obligations Fund	1.82%	3,638,944
21	ONC	BeOne Medicines AG	1.82%	11,745
22	RLAY	Relay Therapeutics, Inc.	1.78%	180,592
23	HALO	Halozyme Therapeutics, Inc.	1.76%	43,145
24	ERAS	Erasca, Inc.	1.71%	186,378
25	ELVN	Enliven Therapeutics, Inc.	1.58%	62,004

Showing 25 of 59 holdings

Subscribe to see the full list

Activate Now

As of Jul 7, 2026